GRFS

Grifols, S.A.

55
Fundamentals59/ 100
Valuation50/ 100
Upside potential55/ 100
Risk potential16/ 100

GRFS lost money over the past year, so it has no meaningful PE right now.

GRFS Fundamentals

MetricStatus
Stable
Strong
Stable
Weak

GRFS's profitability is currently strong, and its revenue and cash flow are stable, but its balance sheet is weak.

GRFS PE Valuation

GRFS has no meaningful PE right now: it lost money over the past year.

GRFS Forward outlook

There aren't enough analyst estimates for GRFS to show an outlook.

GRFS Risk to reward

ScenarioChangePrice
Upside+20%$10.56
Downside-16%$7.37

Calculated from the latest close: $8.80 on Nov 12.

GRFS's one-year upside scenario is somewhat larger than its downside: +20% against −16%.

GRFS Earnings Per Share

Q3 2023: $0.18Q4 2023: $0.23Q1 2024: $0.29Q2 2024: $0.24Q3 2024: $0.23Q4 2024: $0.25Q1 2025: $0.32Q2 2025: $0.48Q3 2025: $0.61Q4 2025: $0.65Q1 2026: $0.68Q2 2026: $0.74
Q3 2023: $0.18Q4 2023: $0.23Q1 2024: $0.29Q2 2024: $0.24Q3 2024: $0.23Q4 2024: $0.25Q1 2025: $0.32Q2 2025: $0.48Q3 2025: $0.61Q4 2025: $0.65Q1 2026: $0.68Q2 2026: $0.74
QuarterTTM EPSYoY
Q2 2026$0.74+54%
Q1 2026$0.68+113%
Q4 2025$0.65+160%
Q3 2025$0.61+165%
Q2 2025$0.48+100%
Q1 2025$0.32+10%
Q4 2024$0.25+8.7%
Q3 2024$0.23+28%

GRFS's earnings per share have fallen from their peak: $0.74 over the past year, against $1.27 in mid-2021.

GRFS Quarterly Revenue

Q3 2023: $1.8BQ4 2023: $2BQ1 2024: $1.8BQ2 2024: $2BQ3 2024: $2BQ4 2024: $2.2BQ1 2025: $2BQ2 2025: $2.1BQ3 2025: $2.1BQ4 2025: $2.2BQ1 2026: $1.9BQ2 2026: $2.1B
Q3 2023: $1.8BQ4 2023: $2BQ1 2024: $1.8BQ2 2024: $2BQ3 2024: $2BQ4 2024: $2.2BQ1 2025: $2BQ2 2025: $2.1BQ3 2025: $2.1BQ4 2025: $2.2BQ1 2026: $1.9BQ2 2026: $2.1B
QuarterRevenueYoY
Q2 2026$2.1B-0.9%
Q1 2026$1.9B-3.2%
Q4 2025$2.2B-0.6%
Q3 2025$2.1B+4%
Q2 2025$2.1B+4%
Q1 2025$2B+9.8%
Q4 2024$2.2B+12%
Q3 2024$2B+12%

GRFS's revenue grew through 2024 and has held roughly level since: $2.1B last quarter, about level with the same quarter a year ago.

GRFS Free Cash Flow

Q3 2023: $79MQ4 2023: $85MQ1 2024: −$225MQ2 2024: $247MQ3 2024: $239MQ4 2024: $460MQ1 2025: $96MQ2 2025: $106MQ3 2025: $284MQ4 2025: $330MQ1 2026: $65MQ2 2026: $120M
Q3 2023: $79MQ4 2023: $85MQ1 2024: −$225MQ2 2024: $247MQ3 2024: $239MQ4 2024: $460MQ1 2025: $96MQ2 2025: $106MQ3 2025: $284MQ4 2025: $330MQ1 2026: $65MQ2 2026: $120M
QuarterFree cash flowYoY
Q2 2026$120M+14%
Q1 2026$65.5M-32%
Q4 2025$329.6M-28%
Q3 2025$283.7M+19%
Q2 2025$105.6M-57%
Q1 2025$95.9M+$321.4M
Q4 2024$460.5M+444%
Q3 2024$239.2M+203%

GRFS generated $799M in free cash flow over the past year, down 11% from the year before.

GRFS Total Shares

Q3 2023: 679MQ4 2023: 679MQ1 2024: 711MQ2 2024: 742MQ3 2024: 680MQ4 2024: 680MQ1 2025: 680MQ2 2025: 689MQ3 2025: 681MQ4 2025: 681MQ1 2026: 681MQ2 2026: 681M
Q3 2023: 679MQ4 2023: 679MQ1 2024: 711MQ2 2024: 742MQ3 2024: 680MQ4 2024: 680MQ1 2025: 680MQ2 2025: 689MQ3 2025: 681MQ4 2025: 681MQ1 2026: 681MQ2 2026: 681M
PeriodChange %Net change
Quarterly0%--
1 year-1.2%-8M shares
3 years+0.3%+2M shares
5 years+6.8%+43.2M shares
Available history-0.5%-3.6M shares

GRFS has 681M diluted shares, down 1.2% from a year ago.

GRFS Net Leverage

Q3 2023: 11.1xQ4 2023: 10.2xQ1 2024: 8.9xQ2 2024: 7.2xQ3 2024: 6.5xQ4 2024: 6.3xQ1 2025: 6.2xQ2 2025: 5.0xQ3 2025: 5.6xQ4 2025: 4.7xQ1 2026: 5.4xQ2 2026: 4.6x
Q3 2023: 11.1xQ4 2023: 10.2xQ1 2024: 8.9xQ2 2024: 7.2xQ3 2024: 6.5xQ4 2024: 6.3xQ1 2025: 6.2xQ2 2025: 5.0xQ3 2025: 5.6xQ4 2025: 4.7xQ1 2026: 5.4xQ2 2026: 4.6x
QuarterNet LeverageStatus
Q2 20264.6xHigh
Q1 20265.4xHigh
Q4 20254.7xHigh
Q3 20255.6xHigh
Q2 20255.0xHigh
Q1 20256.2xHigh
Q4 20246.3xHigh
Q3 20246.5xHigh

GRFS's net debt is about 4.6 years of its operating earnings (EBITDA), down from 5.0 years a year ago.

GRFS Weekly Momentum

MetricValueStatus
RSI65.4Neutral
Stochastic84.5Overbought

GRFS's weekly RSI is 65 (neutral) and its Stochastic is 85 (overbought).

GRFS PE vs Healthcare Sector

MetricGRFSSector medianRelative
PEN/A26x—

GRFS has no meaningful PE right now: it lost money over the past year.

GRFS Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$7.8312% above
20 week MA$7.6914% above
50 week MA$8.158% above
100 week MA$8.365.3% above
200 week MA$8.394.9% above

GRFS has climbed back above all five of its weekly moving averages, and it's now 4.9% above its 200-week average.

GRFS Yearly ROI

YearStart priceEnd priceROI
2020$23.5$18.7-21%
2021$18.7$11.2-40%
2022$11.2$8.12-27%
2023$8.12$11.6+42%
2024$11.6$7.65-34%
2025$7.65$9.10+19%
2026 YTD$9.10$8.80-3.3%

GRFS has finished lower in four of the last six years. It's down 3.3% so far in 2026.

Give your agent the market.

Get API key